<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220611055141N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-08-16</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>The effect of chitosan mouthwash on plaque and gingival indices in patients with fix orthodontic</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of chitosan mouthwash and chitosan-free mouthwash on plaque and gingival indices of fixed orthodontic patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>22</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64173</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, block randomization method is used. For this purpose, using blocks of size 4 including AABB, ABAB, BBAA, etc. is used and selected.
These blocks will be selected using a random number table, Blinding description: This study will be double-blind, in which the patients and the researcher, who is a dentist trained by periodontics specialist will be blind. In this way, patients and researchers in both mouthwash groups will not notice the difference between the mouthwashes due to the similar appearance of the mouthwash bottles.
The result information is also provided by a dentist trained by a periodontics specialist who does not know which group the patient is in.</study_design>
      <phase>3</phase>
      <hc_freetext>PD (Probe Depth);  BOP (Probe on Bleeding);  PI (Plaque Index);  GI (Gingival Index).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Chitosan mouthwash (2 times a day) will be used. Patients should rinse 10cc of mouthwash for 60 seconds at a time and do not consume anything until 30 minutes later .Low molecular weight (75% &lt;DD &lt;85%, MW 107 kDa) and high (75% &lt;DD, MW 624 kDa) chitosan produced by Sigma-Aldrich, St. Louis, USA, for the production of mouthwash will be. Chitosan mouthwash will be produced with 0.4% v / v dose and PH = 5. This compound will be composed of 0.5% (W / V) NaCl salt, 1% (W / V) of Arabic gum stabilizer and 5% (W / V) of Mannitol. After complete solution, food flavor and food coloring are added at a dose of 0.1% (V / V). Intervention 2: Control group: mouthwash without chitosan (2 times a day) will be used. Patients should rinse 10cc of the mouthwash for 60 seconds and not consume anything for 30 minutes after that. Chitosan-free mouthwash with PH=5 will be produced. This composition will be formed with 0.5% (W/V) NaCl salt, 1% (W/V) of Arabic gum stabilizer and 5% (W/V) of Mannitol. After the complete solution, food flavoring and food colors are added at a dose of 0.1% (V/V). Chitosan-free mouthwash is used as a placebo and contains the ingredients mentioned above with the same pH; It is prepared without the main ingredient, which is chitosan. This mouthwash is prepared from the same company from which the original mouthwash is purchased. The container containing the mouthwash and the witness will be similar in appearance so that patients do not notice the difference.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amirmohammad Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 5 , Shahid Aghaee Alley, Shahid Mahmoodi Ave , Shohada Ave</address>
        <city>Varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3371816671</zip>
        <telephone>+98 21 3624 1029</telephone>
        <email>amirjafari7698@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amirmohammad Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 5 , Shahid Aghaee Alley, Shahid Mahmoodi Ave , Shohada Ave</address>
        <city>Varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3371816671</zip>
        <telephone>+98 21 3624 1029</telephone>
        <email>amirjafari7698@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No dental caries
No disease and periodontal surgery
not used antibiotics in the last three months</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Infection in the last six months
diabetes
smoking
Consumption of alcohol
Pregnancy
Cancer
Taking medications that affect periodontal conditions
Systemic conditions require antibiotic prophylaxis prior to periodontal examination
Patients who have a history of fixed orthodontic treatment in the past or any dental treatment during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Chitosan mouthwash (2 times a day) will be used. Patients should rinse 10cc of mouthwash for 60 seconds at a time and do not consume anything until 30 minutes later .Low molecular weight (75% &lt;DD &lt;85%, MW 107 kDa) and high (75% &lt;DD, MW 624 kDa) chitosan produced by Sigma-Aldrich, St. Louis, USA, for the production of mouthwash will be. Chitosan mouthwash will be produced with 0.4% v / v dose and PH = 5. This compound will be composed of 0.5% (W / V) NaCl salt, 1% (W / V) of Arabic gum stabilizer and 5% (W / V) of Mannitol. After complete solution, food flavor and food coloring are added at a dose of 0.1% (V / V).</i_keyword>
      <i_keyword>Control group: mouthwash without chitosan (2 times a day) will be used. Patients should rinse 10cc of the mouthwash for 60 seconds and not consume anything for 30 minutes after that. Chitosan-free mouthwash with PH=5 will be produced. This composition will be formed with 0.5% (W/V) NaCl salt, 1% (W/V) of Arabic gum stabilizer and 5% (W/V) of Mannitol. After the complete solution, food flavoring and food colors are added at a dose of 0.1% (V/V). Chitosan-free mouthwash is used as a placebo and contains the ingredients mentioned above with the same pH; It is prepared without the main ingredient, which is chitosan. This mouthwash is prepared from the same company from which the original mouthwash is purchased. The container containing the mouthwash and the witness will be similar in appearance so that patients do not notice the difference.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Probe depth above 3 mm. Timepoint: Probe depth measurement at the beginning of the study and 30 days after using the mouthwash. Method of measurement: With a Michigan calibrated periodontal probe.</prim_outcome>
      <prim_outcome>Bleeding on probing. Timepoint: Measurement of bleeding during probing at the beginning of the study and 30 days after using the mouthwash. Method of measurement: With a Michigan calibrated periodontal probe.</prim_outcome>
      <prim_outcome>Gingival index. Timepoint: Measurement of gingival index at the beginning of the study and 30 days after using the mouthwash. Method of measurement: Observational.</prim_outcome>
      <prim_outcome>Plaque index. Timepoint: Measuring the plaque index at the beginning of the study and 30 days after using the mouthwash. Method of measurement: The degree of staining of dental plaque after using Fuchsin tablets.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-15</approval_date>
        <contact_name>Ethics Committee of Arak University of Medical Sciences</contact_name>
        <contact_address>Arak University of Medical Sciences, Payambar Azam Complex, Sardasht arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
